Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne NHS Hospitals Foundation Trust, Newcast Upon Tyne, UK.
Chron Respir Dis. 2012 May;9(2):131-45. doi: 10.1177/1479972311435909. Epub 2012 Feb 24.
Lung transplantation is a well-established treatment option for selected patients with end-stage lung disease, leading to improved survival and improved quality of life. The last 20 years have seen a steady growth in number of lung transplantation procedures performed worldwide. The increase in clinical activity has been associated with tremendous progress in the understanding of cellular and molecular processes that limit both short- and long-term outcomes. This review gives a comprehensive overview of the current status of lung transplantation for the referring physician. It demonstrates that careful selection of potential recipients, optimisation of their condition prior to transplant, use of carefully assessed donor organs, excellent surgery and meticulous long-term follow-up are all essential ingredients in determining a successful outcome.
肺移植是治疗终末期肺部疾病的一种成熟治疗选择,可提高患者的生存率和生活质量。在过去的 20 年中,全球肺移植手术的数量稳步增长。临床活动的增加与对限制短期和长期结果的细胞和分子过程的理解取得了巨大进展有关。这篇综述为转诊医生全面介绍了肺移植的现状。它表明,仔细选择潜在的受者,在移植前优化其状况,使用经过仔细评估的供体器官,精湛的手术和精心的长期随访,都是决定手术成功的关键因素。